Venezuela and Fentanyl: Dismantling the US Narrative With Data From the US Government

By Misión Verdad – Oct 1, 2025

Amid political rhetoric that has sought to link Venezuela to the fentanyl crisis in the United States, a recent official document from the US government itself categorically refutes that accusation.

The International Narcotics Control Strategy Report 2025 (INCSR), published in March by the US State Department’s Bureau of International Narcotics and Law Enforcement Affairs, makes clear that Mexico is the sole significant source of illicit fentanyl and its analogues that have affected the United States in 2024.

This finding is conclusive: Venezuela is not mentioned as a producer country, a transit route, or a relevant actor in the trafficking of fentanyl into US territory.

Moreover, the report underscores that according to seizure data and police investigations, the competent authorities—including the DEA (Drug Enforcement Administration)—agree that the entire illicit fentanyl supply chain originates in Mexico, where synthetic pills and powders are manufactured using chemical precursors primarily sourced from China.

The contradiction between the political narrative and the technical facts
Recently, US President Donald Trump has tried to link Venezuela to fentanyl trafficking, even justifying military operations in the Caribbean—such as precision strikes against small vessels—as part of a supposed anti-drug strategy.

However, none of these claims is supported by the US government’s own technical reports and official classifications. The INCSR 2025, which relies on intelligence, joint operations, and forensic analysis, entirely omits Venezuela from the fentanyl map.

This discrepancy between political rhetoric and institutional evidence raises doubts about the true motives behind the accusations against Venezuela, as it amounts to a weaponization of the drug problem for geopolitical purposes. Or does it reflect a dangerous oversimplification that ignores the complexity of global drug trafficking? It would hardly be the case.

The truth is that, when comparing public statements with official documents, a deliberate discrepancy becomes evident between what is said in the political arena and what is acknowledged in technical offices.

Venezuela’s structural absence from the fentanyl market
Apart from what the US report states, there are structural reasons why Venezuela is not involved in fentanyl trafficking:

Lack of chemical infrastructure: Fentanyl is a synthetic opioid that requires sophisticated laboratories and access to highly regulated chemical precursors. Venezuela, with its pharmaceutical and chemical industries dedicated to national development efforts, lacks the technical and logistical capacity to produce it on a large scale. There are no indications of existence of clandestine laboratories specializing in synthetic opioids in the country, not even in areas where organized crime exists.
Geography and drug trafficking routes: Fentanyl routes to the US are primarily overland, crossing the US southern border from Mexico. The Caribbean, although historically used for cocaine trafficking, is neither an efficient nor a common route for transporting fentanyl, which is a high-value drug that is moved in small quantities, making it ideal for smuggling by land or by mail. Small vessels—which Trump has attributed to transporting fentanyl from Venezuela—make no logistical sense in this context: fentanyl does not need to be transported in large volumes, and its massive entry into the US market is primarily carried out via parcel delivery, private vehicles, or established distribution networks in border cities.
Historical pattern of Venezuelan trafficking: Venezuela has never been associated with synthetic opioids. Fentanyl is neither grown nor refined, unlike cocaine. The production of fentanyl is industrial and highly specialized, something foreign to the drug trafficking model in the Andean and Caribbean regions. Venezuelan criminal organizations, when they have engaged in drug trafficking, have done so within the Colombian cocaine trade (on a very small scale), not in the manufacture of synthetic substances.

The Fentanyl Epidemic Driven by Profit: Made in USA

The weight of institutional evidence
The INCSR 2025 is the US government’s most comprehensive and authoritative annual report on the global state of drug trafficking. Its preparation involves multiple agencies: the DEA, the Department of Justice, the Department of Homeland Security, and US embassies around the world. Its conclusions guide resource allocation, international cooperation, and diplomatic decisions in drug enforcement.

The fact that Venezuela is not even mentioned in this document in connection with fentanyl is a deliberate decisioin based on years of monitoring, interceptions, and intelligence analysis.

Moreover, the report not only identifies Mexico as the sole significant source but also details US–Mexico bilateral cooperation mechanisms, regulatory measures on pill manufacturing machines, and joint efforts to control chemical precursors.

This shows that the US anti-drug strategy is focused on the Mexico–US axis. Venezuela is not part of that axis; it is not even on the fringes.

Political consequences
When Trump attributes complex problems to the wrong origin, he not only distorts reality but also generates practical consequences. For example, military operations in the Caribbean, justified under the false premise that Venezuelan fentanyl is being intercepted, divert resources from genuine lines of action.

Furthermore, they fuel misconceptions in public opinion, making it difficult to develop effective, fact-based policies.

Even worse, these unfounded accusations undermine US credibility in international forums. If a country accuses another of illicit activities without presenting verifiable evidence—and, worse, in contradiction to its own official reports—its moral and diplomatic standing is weakened.

The fight against drugs requires cooperation, transparency, and technical rigor. The politicization of information weakens it.

Towards a fact-based drug policy
The case of fentanyl and Venezuela illustrates that US drug policies are not based on evidence but on convenient political narratives. It is a distortion of reality that diverts resources, attention, and cooperation from the true sources of the problem in order to forcibly bring about regime change in a country.

The United States suffers an overdose epidemic that in 2024 alone claimed more than 80,000 lives due to fentanyl overdose. To tackle it effectively, the United States must focus on strengthening cooperation with Mexico, better regulating chemical precursors globally, and addressing the root causes of addiction within its own borders: access to fentanyl, mental health crisis, inequality, and social despair.

Meanwhile, Venezuela has been exonerated—by the very most authoritative US sources—of any involvement in fentanyl trafficking; it is not part of the fentanyl supply chain.

Trump is only arguing about this issue because he is constantly being provoked, especially by the State Department, that he must launch a violent military campaign against Venezuela.

(Misión Verdad)

Translation: Orinoco Tribune

OT/SC/SL